Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELIA trial of metformin for antipsychotic-induced weight gain
2020-000053-27Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in antipsychotic-induced weight gain (AIWG) comparing Metformin plus lifestyle intervention with Placebo plus lifestyle intervention (2 arms). Started May 2020; status: completed.
02
Drugs
metformin
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on 2020-000053-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000053-27.